|
After successfully working together for a number of years on various international projects, Christopher S. Record and Marco Mastrodonato decided in mid-1998 to combine resources, experience and pharmaceutical industry knowledge to form the Propharma Corporation based in Dallas, Texas with offices in Milan, Italy. Propharma’s objective is to develope, license or acquire innovative niche products for the international marketplace. Initially, the company will focus its efforts on four key markets: Wound Care, Dermatologic Care, Oral Care and Infection Control. Propharma will offer unique products with identifiable competitive advantages it owns or has exclusive rights to distribute in agreed upon territories. These products will fill unmet needs in the defined markets that the company and its partners believe can grow into profitable, larger market opportunities over time. Propharma will work with a limited number of companies in Europe, the United States, Middle East and Asia that have compatible philosophies and do not conflict or compete in their core markets with other Propharma partners. The company believes that with continued consolidation in the pharmaceutical industry middle market companies that may be market leaders in their country of origin or even in a region must be willing to partner with other companies similarly situated in order to remain as profitable and competitive as they have been in the past as they begin to compete against large multi-national conglomerates with enormous resources. In this ever-changing pharmaceutical market of mega mergers, companies must be able to act quickly to acquire or license innovative products as soon as they appear in one regional market or another in order to remain competitive.
Activity:
- Sales & Distribution
Product / Technology type(s) covered:
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
Therapeutic targets:
|
|
Add
Company
Subscribe
Search
Contact
